Temporomandibular Joint Disorders
Conditions
Interventions
This is a randomized clinical trial, paralell, blinded. The sample will consist of 90 participants who have had myalgias related to temporomandibular disorder (TMD) for longer than 6 months and who wi
GII (n=30) treated with the anterior partial splint
GIII (n=30) control group that will receive guidelines for self-care. Randomization will be kept in sealed envelopes, being opened only at the time of intervention. The initial assessments of patients
Sponsors
Universidade Federal dos Vales do Jequitinhonha e Mucuri
Universidade Federal dos Vales do Jequitinhonha e Mucuri
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Having myalgias related to Temporomandibular Disorders (TMDs) for longer than 6 months; myalgias located in the temporal region accompanied, or not, by other facial myalgias; be aged 18 years or over; both genders; pain on palpation with a score greater than or equal to 7 on the numeric rating scale; pain related to functional and/or parafunctional activities of the stomatognathic system
Exclusion criteria
Exclusion criteria: Patient undergoing physiotherapeutic and/or speech therapy treatments that have repercussions on muscle, joint and/or skeletal structures in the head and neck region; who have undergone some type of temporomandibular joint procedure in the last 12 months; patients with facial paralysis; patients undergoing orthodontic treatment; complete denture users; who underwent a procedure using botulinum toxin in the head and neck region in the last 6 months; patients using Selective Serotonin Reuptake Inhibitors (SSRI) antidepressants; patients undergoing psychological treatment; patients who have cognitive and/or neuromotor difficulties that compromise the stages of the study's development
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain: All patients will be instructed to define their pain level on a numerical scale from 0 to 10. This parameter will be evaluated baseline, 1, 3 and 6 months after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life: participants will respond a oral health related quality of life questionnaire, before and 3 months after treatment.;Adverse effects: participants will report adversal effects correlated to the treatment. This will be evaluated 7 days after the treatment. | — |
Countries
Brazil
Contacts
Public ContactDhelfeson Oliveira
Universidade Federal dos Vales do Jequitinhonha e Mucuri
Outcome results
None listed